心血管

订阅

MedSci主页 / 所有栏目 / 心血管

Heart：二尖瓣脱垂是开角型青光眼的显著预测因素

2014-12-16 小田 译 医学论坛网

二尖瓣脱垂开角型青光眼
关注

台湾学者的一项基于人群的回顾性队列研究表明，既往存在二尖瓣脱垂是罹患开角型青光眼的显著预测因素。相关论文12月11日在线发表于《心脏》(Heart)杂志。 研究者们随机选取了纵向健康保险数据库中的1 073 891个样本，对其随访13年，其中倾向性评分相匹配的有和无二尖瓣脱垂患者数分别为21 677例和86 708例，作为对照。利用Cox比例风险模型进行分析和校正多个并病，以评估二尖瓣脱

台湾学者的一项基于人群的回顾性队列研究表明，既往存在二尖瓣脱垂是罹患开角型青光眼的显著预测因素。相关论文12月11日在线发表于《心脏》(Heart)杂志。


研究者们随机选取了纵向健康保险数据库中的1 073 891个样本，对其随访13年，其中倾向性评分相匹配的有和无二尖瓣脱垂患者数分别为21 677例和86 708例，作为对照。利用Cox比例风险模型进行分析和校正多个并病，以评估二尖瓣脱垂患者的开角型青光眼的校正危险比(HR)。

结果显示，无二尖瓣脱垂组和二尖瓣脱垂组的开角型青光眼发生率分别为10.17和16.05每10 000人-年。二尖瓣脱垂组的开角型青光眼校正HR为1.88。在二尖瓣脱垂患者的4个分层的年龄组中，开角型青光眼风险也显著增加。Kaplan–Meier分析显示，与对照组相比，随访期间二尖瓣脱垂组的开角型青光眼发生率更高(P<0.001)。

原始出处：

Shuo Ju Chiang1,2, Masao Daimon3, Li Hsuan Wang4,5, Ming-Jui Hung6, Nen Chung Chang1,2, Hsiu Chen Lin7,8.Association between mitral valve prolapse and open-angle glaucoma.Heart doi:10.1136/heartjnl-2014-306198



您还可以这样阅读，更多资讯，请关注MedSci微信
  

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-28 qingting

    #开角型#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2015-02-07 ms6829001416292975

    #二尖瓣脱垂#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-18 朱睿睿

    #预测因素#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-18 智智灵药

    #ART#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-18 wwzzly

    #二尖瓣#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-18 爆笑小医

    #HEART#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2046540, encodeId=3e122046540c7, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Dec 28 08:31:00 CST 2014, time=2014-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044837, encodeId=ad00204483e59, content=<a href='/topic/show?id=40fd23918d0' target=_blank style='color:#2F92EE;'>#二尖瓣脱垂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23918, encryptionId=40fd23918d0, topicName=二尖瓣脱垂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Sat Feb 07 00:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264214, encodeId=343e12642149d, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355945, encodeId=c0d31355945d2, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463139, encodeId=e46f146313904, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562274, encodeId=5b5315622e4e8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630777, encodeId=682a1630e771a, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Thu Dec 18 00:31:00 CST 2014, time=2014-12-18, status=1, ipAttribution=)]
    2014-12-18 surilei

    #开角型青光眼#

    0